Stabilized Peptide HDAC Inhibitors Derived From HDAC1 Substrate H3K56 for the Treatment of Cancer Stem-Like Cells in Vivo
Cancer Research - United States
doi 10.1158/0008-5472.can-18-1421
Full Text
Open PDFAbstract
Available in full text
Date
March 6, 2019
Authors
Publisher
American Association for Cancer Research (AACR)